An overview on pharmacist-managed prescription renewal
Main Article Content
Keywords
Adherence, pharmacist, healthcare outcomes, prescription renewal
Abstract
To enhance patient care and clinical outcomes while minimizing administrative burdens, a new model of chronic disease management has been tested. This model focuses on the value of inter-professional collaboration and aims to reduce the administrative workload of primary care providers, particularly physicians at healthcare centres. Pharmacists, as essential healthcare providers, play a crucial role in the medication cycle, and pharmacist-led prescription renewal for chronic oral medication has emerged as a potential intervention to improve adherence and treatment outcomes. The success of therapy is dependent on patient adherence. Understanding the reasons behind non-adherence and identifying strategies to address this situation can improve healthcare outcomes. The implementation of prescription renewal in community pharmacies may benefit patients, healthcare professionals and society in general. By focusing on patient well-being and promoting collaboration among healthcare providers, it is possible to enhance adherence rates and optimize patient care.
References
1. Portugal: Country Health Profile 2021. 2021 Dec 13; DOI: 10.1787/8F3B0171-EN
2. Análise de consumo de medicamentos em meio ambulatório - Ambulatório - INFARMED, I.P. Available at:https://www. infarmed.pt/web/infarmed/profissionais-de-saude/utilizacao-edespesa/relatorios/ambulatorio
3. WHO. Guidance on the use of International Nonproprietary Names (INNs) 2017. Available at: https://www.who.int/ publications/m/item/guidance-on-the-use-of-inns
4. Rutter P. Role of community pharmacists in patients’ self-care and self-medication. Integr Pharm Res Pract. 2015 Jun; 4:57.DOI: 10.2147/IPRP.S70403
5. White N. Reducing Primary Care Provider Burnout With Pharmacist-Delivered Comprehensive Medication Management. Am J Lifestyle Med. 2020 Mar 1;15(2):133–5. DOI: 10.1177/1559827620976539
6. Newman T V., San-Juan-Rodriguez A, Parekh N, Swart ECS, Klein-Fedyshin M, Shrank WH, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review. Res Social Adm Pharm. 2020 Sep 1;16(9):1155–65. DOI: 10.1016/J.SAPHARM.2019.12.016
7. Akers JM, Shah A, Jay A, Pfund T. Pharmacists’ Role in Chronic Disease Management from Physicians’ Perspective. Inov Pharm. 2019 May 24;10(2):15. DOI: 10.24926/IIP.V10I2.1449
8. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012 May; 73(5):691. DOI: 10.1111/J.1365-2125.2012.04167.X
9. Leporini C, De Sarro G, Russo E. Adherence to therapy and adverse drug reactions: is there a link? Expert Opin Drug Saf. 2014;
13 Suppl 1(SUPPL. 1). DOI: 10.1517/14740338.2014.947260
10. Wolff JL, Giovannetti ER, Boyd CM, Reider L, Palmer S, Scharfstein D, et al. Effects of guided care on family caregivers. Gerontologist. 2010;50(4):459–70. DOI: 10.1093/GERONT/GNP124
11. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005 Jun;43(6):521–30. DOI: 10.1097/01.MLR.0000163641.86870.AF
12. €125 billion lost each year across Europe due to non-adherence to medication - ILCUK Available at: https://ilcuk.org.uk/125- billion-lost-each-year-due-to-non-adherence/
13. Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018 Jan 1;8(1). DOI: 10.1136/BMJOPEN-2017-016982
14. Almomani BA, Hijazi BM, Awwad O, Khasawneh RA. Prevalence and predictors of non-adherence to short-term antibiotics: A population-based survey. PLoS One. 2022 May 1;17(5). DOI: 10.1371/JOURNAL.PONE.0268285
15. Lam WY, Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int. 2015;2015. DOI: 10.1155/2015/217047
16. Gil-Guillen VF, Balsa A, Bernárdez B, Valdés y Llorca C, Márquez-Contreras E, de la Haba-Rodríguez J, et al. Medication Non- Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions. Int J Environ Res Public Health. 2022 Oct 1;19(19). DOI: 10.3390/IJERPH191912036
17. Cabral MV, Silva PA da. A adesão à terapêutica em Portugal : atitudes e comportamentos da população portuguesa perante as prescrições médicas, os hábitos de saúde e o consumo de medicamentos. Inst Ciências Sociais da Univ Lisboa. 2010; Available at: https://repositorio.ul.pt/handle/10451/11160
18. Assawasuwannakit P, Braund R, Duffull SB. A model-based meta-analysis of the influence of factors that impact adherence to medications. J Clin Pharm Ther. 2015 Feb 1;40(1):24–31. DOI: 10.1111/JCPT.12219
19. Tavares AI, Marques I. Multi-layer health insurance coverage, medical services use and health in a Universal National Health System, the case of Portugal. Eur J Health Econ. 2021 Feb 1;22(1):141–53. DOI: 10.1007/S10198-020-01242-4
20. Ficheiros Coesão Territorial - XXI Governo - República Portuguesa. Available at: https://www.portugal.gov.pt/pt/gc21/governo/programa/programa-nacional-para-a-coesao-territorial-/ficheiros-coesao-territorial.aspx
21. Costa C, Tenedório JA, Santana P. Disparities in Geographical Access to Hospitals in Portugal. ISPRS Int J Geo-Information 2020, Vol 9, Page 567. 2020 Sep 29;9(10):567. DOI: 10.3390/IJGI9100567
22. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–14. DOI: 10.4065/MCP.2010.0575
23. Haskard Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009 Aug;47(8):826–34. DOI: 10.1097/MLR.0B013E31819A5ACC
24. Kolios AGA, Hueber AJ, Michetti P, Mrowietz U, Mustak-Blagusz M, Sator PG, et al. ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study. J Eur Acad Dermatology Venereol. 2019;33(1):234–41.
25. Medication safety in transitions of care. Available at: https://www.who.int/publications/i/item/WHO-UHC-SDS-2019.9
26. Gebreyohannes EA, Bhagavathula AS, Abebe TB, Tefera YG, Abegaz TM. Adverse effects and non-adherence to antihypertensive medications in University of Gondar Comprehensive Specialized Hospital. Clin Hypertens. 2019 Jan 15;25(1). DOI: 10.1186/ S40885-018-0104-6
27. Burge S, White D, Bajorek E, Bazaldua O, Trevino J, Albright T, et al. Correlates of medication knowledge and adherence: Findings from the Residency Research Network of South Texas. Fam Med. 2005;37(10):712–8.
28. AL-Jahdali H, Ahmed A, AL-Harbi A, Khan M, Baharoon S, Bin Salih S, et al. Improper inhaler technique is associated with
poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol. 2013 Mar 6;9(1):8. DOI: 10.1186/1710-1492-9-8
29. Benson H, Lucas C, Benrimoj SI, Williams KA. The development of a role description and competency map for pharmacists in an interprofessional care setting. Int J Clin Pharm. 2019 Apr 1;41(2):391–407. DOI: 10.1007/S11096-019-00808-4
30. Adherence and Concordance EPF Position Paper. 2015; Available at: http://abcproject.eu/img/ABC Final.pdf
31. Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, et al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014 Apr 1;31(4):283–9. DOI: 10.1007/S40266-014-0163-7
32. Syed ST, Gerber BS, Sharp LK. Traveling Towards Disease: Transportation Barriers to Health Care Access. J Community Health. 2013 Oct;38(5):976. DOI: 10.1007/S10900-013-9681-1
33. Schulman-Green D, Feder SL, Dionne-Odom JN, Batten J, En Long VJ, Harris Y, et al. Family Caregiver Support of Patient Self- Management During Chronic, Life-Limiting Illness: A Qualitative Metasynthesis. J Fam Nurs. 2021;27(1):55–72.
34. Faries MD, Abreu A. Medication Adherence, When Lifestyle Is the Medicine. Am J Lifestyle Med. 2017 Sep 1;11(5):397. DOI: 10.1177/1559827617697922
35. Pérez-Jover V, Sala-González M, Guilabert M, Mira JJ. Mobile Apps for Increasing Treatment Adherence: Systematic Review. J Med Internet Res. 2019 Jun 1;21(6). DOI: 10.2196/12505
36. Park HR, Kang HS, Kim SH, Singh-Carlson S. Effect of a Smart Pill Bottle Reminder Intervention on Medication Adherence, Self-efficacy, and Depression in Breast Cancer Survivors. Cancer Nurs. 2022 Nov 1;45(6):E874–82. DOI: 10.1097/ NCC.0000000000001030
37. Karagiannis D, Mitsis K, Nikita KS. Development of a Low-Power IoMT Portable Pillbox for Medication Adherence Improvement and Remote Treatment Adjustment. Sensors. 2022;22(15).
38. Rahayu SA, Widianto S, Defi IR, Abdulah R. Role of Pharmacists in the Interprofessional Care Team for Patients with Chronic Diseases. J Multidiscip Healthc [Internet]. 2021;14:1701–10. DOI: 10.2147/JMDH.S309938
39. Moutinho A, Alexandra D, Rodrigues R. SwapINN: Analytic Study about Prescription Swaps at Pharmacies. Acta Med Port. 2014 Jan 8;27(1):92–8. DOI: 10.20344/AMP.4278
40. Gavrilova A, Zolovs M, Latkovskis G, Urtāne I. The Impact of International Nonproprietary Names Integration on Prescribing Reimbursement Medicines for Arterial Hypertension and Analysis of Medication Errors in Latvia. Int J Environ Res Public Heal 2022, Vol 19, Page 10156. 2022 Aug 16;19(16):10156. DOI: 10.3390/IJERPH191610156
41. E-prescribing and dispensing of medicines in Europe. Available at: https://www.sns24.gov.pt/guia/a-minha-saude-na-europa/ prescricao-eletronica-e-dispensa-de-medicamentos-na-europa/
42. McKesson Europe Policy Position. 2018; Available at: https://ec.europa.eu/health/sites/health/files/ehealth/docs/ev_20161121_co091_en.pdf
43. Prescrição e dispensa - INFARMED, I.P. Available at: https://www.infarmed.pt/web/infarmed/profissionais-de-saude/ prescricao-e-dispensa
44. Ciências Farmacêuticas • EduPortugal. Available at: https://eduportugal.eu/opcoes-de-estudo/ciencias-farmaceuticas/
45. Paudyal V, Fialová D, Henman MC, Hazen A, Okuyan B, Lutters M, et al. Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy. Int J Clin Pharm. 2021 Aug; 43(4):1139–48. DOI: 10.1007/ S11096-021-01301-7
46. Portaria n.o 289/2023 | DR. Available at: https://diariodarepublica.pt/dr/detalhe/portaria/289-2023-222046015
47. Piraux A, Cavillon M, Ramond-Roquin A, Faure S. Assessment of Satisfaction with Pharmacist-Administered COVID-19 Vaccinations in France: PharmaCoVax. Vaccines. 2022 Mar 1;10(3). DOI: 10.3390/VACCINES10030440
48. French pharmacists now able to renew some doctor’s prescriptions. Available at: https://www.connexionfrance.com/practical/ french-pharmacists-now-able-to-renew-some-doctors-prescriptions/434978
49. Pharmacists in France allowed to renew and adjust repeat prescriptions. Available at: https://www.connexionfrance.com/ practical/pharmacists-in-france-allowed-to-renew-and-adjust-repeat-prescriptions/408024
50. van Loon WE, Borgsteede SD, Baas GW, Kruijtbosch M, Buurma H, De Smet PAGMP, et al. Nature and frequency of prescription modifications in community pharmacies: A nationwide study in the Netherlands. Br J Clin Pharmacol. 2021;87(3):1455–65.
51. Orçamento do Estado para 2023 | DR. Available at: https://diariodarepublica.pt/dr/legislacao-consolidada/lei/2022- 205695052
52. Portaria n.o 263/2023 | DR. Available at: https://diariodarepublica.pt/dr/detalhe/portaria/263-2023-219991258
53. A Vision for Community Pharmacy in Europe.
54. Statistics Portugal - Web Portal. Available at: https://www.ine.pt/xportal/xmain?xpid=INE&xpgid=ine_main
55. Chronic diseases and disabilities among older people | Health at a Glance: Europe 2022 : State of Health in the EU Cycle | OECD iLibrary. Available at: https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-europe- 2022_851d74d6-en
56. A pordata | PORDATA. Available at: https://www.pordata.pt/pt/pordata
57. Waszyk-Nowaczyk M, Guzenda W, Kamasa K, Pawlak K, Bałtruszewicz N, Artyszuk K, et al. Cooperation between pharmacists and physicians – whether it was before and is it still ongoing during the pandemic? J Multidiscip Healthc. 2021;14:2101–10.
58. Zhou S, Li R, Zhang X, Zong Y, Lei L, Tao Z, et al. The effects of pharmaceutical interventions on potentially inappropriate medications in older patients: a systematic review and meta-analysis. Front public Heal. 2023;11. DOI: 10.3389/FPUBH.2023.1154048
59. Hurmuz MZM, Janus SIM, van Manen JG. Changes in medicine prescription following a medication review in older high-risk patients with polypharmacy. Int J Clin Pharm. 2018 Apr 1;40(2):480–7. DOI: 10.1007/S11096-018-0602-3
60. Heinrich CH, McHugh S, McCarthy S, Curran GM, Donovan MD. Multidisciplinary DEprescribing review for Frail oldER adults in long-term care (DEFERAL): Implementation strategy design using behaviour science tools and stakeholder engagement. ResSocial Adm Pharm. 2023 Aug 1;19(8):1202–13. DOI: 10.1016/J.SAPHARM.2023.05.002
61. Harjaningsih W, Harjaningsih W. The Role of Clinical Pharmacists as a Collaborative Team for Ambulatory Care in Schizophrenic Patients. Curr Trends Ambul Care. 2023 Apr 26; DOI: 10.5772/INTECHOPEN.111507
62. Hammour KA, Farha RA, Ya’acoub R, Salman Z, Basheti I. Impact of Pharmacist-Directed Medication Reconciliation in Reducing Medication Discrepancies: A Randomized Controlled Trial. Can J Hosp Pharm. 2022 Jun 1;75(3):169–77. DOI: 10.4212/CJHP.3143
63. Amjad A, Kordel P, Fernandes G. A Review on Innovation in Healthcare Sector (Telehealth) through Artificial Intelligence. Sustain 2023, Vol 15, Page 6655. 2023 Apr 14;15(8):6655. DOI: 10.3390/SU15086655
64. Rahayu SA, Widianto S, Defi IR, Abdulah R. Role of pharmacists in the interprofessional care team for patients with chronic diseases. J Multidiscip Healthc. 2021;14:1701–10.
65. Ihm SH, Kim K Il, Lee KJ, Won JW, Na JO, Rha SW, et al. Interventions for Adherence Improvement in the Primary Prevention of Cardiovascular Diseases: Expert Consensus Statement. Korean Circ J. 2022 Jan 1;52(1). DOI: 10.4070/KCJ.2021.0226
66. Félix J, Ferreira D, Afonso-Silva M, Gomes MV, Ferreira C, Vandewalle B, et al. Social and economic value of Portuguese community pharmacies in health care. BMC Health Serv Res. 2017 Aug 29;17(1):1–12. DOI: 10.1186/S12913-017-2525-4/ TABLES/2
67. van Loon WE, Borgsteede SD, Baas GW, Kruijtbosch M, Buurma H, De Smet PAGMP, et al. Nature and frequency of prescription modifications in community pharmacies: A nationwide study in the Netherlands. Br J Clin Pharmacol. 2021 Mar 1; 87(3):1455–
65. DOI: 10.1111/BCP.14548
68. Smale EM, Egberts TCG, Heerdink ER, van den Bemt BJF, Bekker CL. Waste-minimising measures to achieve sustainable supply and use of medication. Sustain Chem Pharm. 2021 May 1;20.
69. Hurley-Kim K, Keyvani A, Ahmed R, Wong HW, McBane S. Pharmacist-Managed Refill Service Impacts on Clinician Workload and Medication Interventions in a Federally Qualified Health Center. J Prim Care Community Heal. 2023;14.
70. Billups SJ, Delate T, Newlon C, Schwiesow S, Jahnke R, Nadrash A. Outcomes of a pharmacist-managed medication refill program. J Am Pharm Assoc (2003). 2013;53(5):505–12. DOI: 10.1331/JAPHA.2013.13008
2. Análise de consumo de medicamentos em meio ambulatório - Ambulatório - INFARMED, I.P. Available at:https://www. infarmed.pt/web/infarmed/profissionais-de-saude/utilizacao-edespesa/relatorios/ambulatorio
3. WHO. Guidance on the use of International Nonproprietary Names (INNs) 2017. Available at: https://www.who.int/ publications/m/item/guidance-on-the-use-of-inns
4. Rutter P. Role of community pharmacists in patients’ self-care and self-medication. Integr Pharm Res Pract. 2015 Jun; 4:57.DOI: 10.2147/IPRP.S70403
5. White N. Reducing Primary Care Provider Burnout With Pharmacist-Delivered Comprehensive Medication Management. Am J Lifestyle Med. 2020 Mar 1;15(2):133–5. DOI: 10.1177/1559827620976539
6. Newman T V., San-Juan-Rodriguez A, Parekh N, Swart ECS, Klein-Fedyshin M, Shrank WH, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review. Res Social Adm Pharm. 2020 Sep 1;16(9):1155–65. DOI: 10.1016/J.SAPHARM.2019.12.016
7. Akers JM, Shah A, Jay A, Pfund T. Pharmacists’ Role in Chronic Disease Management from Physicians’ Perspective. Inov Pharm. 2019 May 24;10(2):15. DOI: 10.24926/IIP.V10I2.1449
8. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012 May; 73(5):691. DOI: 10.1111/J.1365-2125.2012.04167.X
9. Leporini C, De Sarro G, Russo E. Adherence to therapy and adverse drug reactions: is there a link? Expert Opin Drug Saf. 2014;
13 Suppl 1(SUPPL. 1). DOI: 10.1517/14740338.2014.947260
10. Wolff JL, Giovannetti ER, Boyd CM, Reider L, Palmer S, Scharfstein D, et al. Effects of guided care on family caregivers. Gerontologist. 2010;50(4):459–70. DOI: 10.1093/GERONT/GNP124
11. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005 Jun;43(6):521–30. DOI: 10.1097/01.MLR.0000163641.86870.AF
12. €125 billion lost each year across Europe due to non-adherence to medication - ILCUK Available at: https://ilcuk.org.uk/125- billion-lost-each-year-due-to-non-adherence/
13. Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018 Jan 1;8(1). DOI: 10.1136/BMJOPEN-2017-016982
14. Almomani BA, Hijazi BM, Awwad O, Khasawneh RA. Prevalence and predictors of non-adherence to short-term antibiotics: A population-based survey. PLoS One. 2022 May 1;17(5). DOI: 10.1371/JOURNAL.PONE.0268285
15. Lam WY, Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int. 2015;2015. DOI: 10.1155/2015/217047
16. Gil-Guillen VF, Balsa A, Bernárdez B, Valdés y Llorca C, Márquez-Contreras E, de la Haba-Rodríguez J, et al. Medication Non- Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions. Int J Environ Res Public Health. 2022 Oct 1;19(19). DOI: 10.3390/IJERPH191912036
17. Cabral MV, Silva PA da. A adesão à terapêutica em Portugal : atitudes e comportamentos da população portuguesa perante as prescrições médicas, os hábitos de saúde e o consumo de medicamentos. Inst Ciências Sociais da Univ Lisboa. 2010; Available at: https://repositorio.ul.pt/handle/10451/11160
18. Assawasuwannakit P, Braund R, Duffull SB. A model-based meta-analysis of the influence of factors that impact adherence to medications. J Clin Pharm Ther. 2015 Feb 1;40(1):24–31. DOI: 10.1111/JCPT.12219
19. Tavares AI, Marques I. Multi-layer health insurance coverage, medical services use and health in a Universal National Health System, the case of Portugal. Eur J Health Econ. 2021 Feb 1;22(1):141–53. DOI: 10.1007/S10198-020-01242-4
20. Ficheiros Coesão Territorial - XXI Governo - República Portuguesa. Available at: https://www.portugal.gov.pt/pt/gc21/governo/programa/programa-nacional-para-a-coesao-territorial-/ficheiros-coesao-territorial.aspx
21. Costa C, Tenedório JA, Santana P. Disparities in Geographical Access to Hospitals in Portugal. ISPRS Int J Geo-Information 2020, Vol 9, Page 567. 2020 Sep 29;9(10):567. DOI: 10.3390/IJGI9100567
22. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–14. DOI: 10.4065/MCP.2010.0575
23. Haskard Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009 Aug;47(8):826–34. DOI: 10.1097/MLR.0B013E31819A5ACC
24. Kolios AGA, Hueber AJ, Michetti P, Mrowietz U, Mustak-Blagusz M, Sator PG, et al. ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study. J Eur Acad Dermatology Venereol. 2019;33(1):234–41.
25. Medication safety in transitions of care. Available at: https://www.who.int/publications/i/item/WHO-UHC-SDS-2019.9
26. Gebreyohannes EA, Bhagavathula AS, Abebe TB, Tefera YG, Abegaz TM. Adverse effects and non-adherence to antihypertensive medications in University of Gondar Comprehensive Specialized Hospital. Clin Hypertens. 2019 Jan 15;25(1). DOI: 10.1186/ S40885-018-0104-6
27. Burge S, White D, Bajorek E, Bazaldua O, Trevino J, Albright T, et al. Correlates of medication knowledge and adherence: Findings from the Residency Research Network of South Texas. Fam Med. 2005;37(10):712–8.
28. AL-Jahdali H, Ahmed A, AL-Harbi A, Khan M, Baharoon S, Bin Salih S, et al. Improper inhaler technique is associated with
poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol. 2013 Mar 6;9(1):8. DOI: 10.1186/1710-1492-9-8
29. Benson H, Lucas C, Benrimoj SI, Williams KA. The development of a role description and competency map for pharmacists in an interprofessional care setting. Int J Clin Pharm. 2019 Apr 1;41(2):391–407. DOI: 10.1007/S11096-019-00808-4
30. Adherence and Concordance EPF Position Paper. 2015; Available at: http://abcproject.eu/img/ABC Final.pdf
31. Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, et al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014 Apr 1;31(4):283–9. DOI: 10.1007/S40266-014-0163-7
32. Syed ST, Gerber BS, Sharp LK. Traveling Towards Disease: Transportation Barriers to Health Care Access. J Community Health. 2013 Oct;38(5):976. DOI: 10.1007/S10900-013-9681-1
33. Schulman-Green D, Feder SL, Dionne-Odom JN, Batten J, En Long VJ, Harris Y, et al. Family Caregiver Support of Patient Self- Management During Chronic, Life-Limiting Illness: A Qualitative Metasynthesis. J Fam Nurs. 2021;27(1):55–72.
34. Faries MD, Abreu A. Medication Adherence, When Lifestyle Is the Medicine. Am J Lifestyle Med. 2017 Sep 1;11(5):397. DOI: 10.1177/1559827617697922
35. Pérez-Jover V, Sala-González M, Guilabert M, Mira JJ. Mobile Apps for Increasing Treatment Adherence: Systematic Review. J Med Internet Res. 2019 Jun 1;21(6). DOI: 10.2196/12505
36. Park HR, Kang HS, Kim SH, Singh-Carlson S. Effect of a Smart Pill Bottle Reminder Intervention on Medication Adherence, Self-efficacy, and Depression in Breast Cancer Survivors. Cancer Nurs. 2022 Nov 1;45(6):E874–82. DOI: 10.1097/ NCC.0000000000001030
37. Karagiannis D, Mitsis K, Nikita KS. Development of a Low-Power IoMT Portable Pillbox for Medication Adherence Improvement and Remote Treatment Adjustment. Sensors. 2022;22(15).
38. Rahayu SA, Widianto S, Defi IR, Abdulah R. Role of Pharmacists in the Interprofessional Care Team for Patients with Chronic Diseases. J Multidiscip Healthc [Internet]. 2021;14:1701–10. DOI: 10.2147/JMDH.S309938
39. Moutinho A, Alexandra D, Rodrigues R. SwapINN: Analytic Study about Prescription Swaps at Pharmacies. Acta Med Port. 2014 Jan 8;27(1):92–8. DOI: 10.20344/AMP.4278
40. Gavrilova A, Zolovs M, Latkovskis G, Urtāne I. The Impact of International Nonproprietary Names Integration on Prescribing Reimbursement Medicines for Arterial Hypertension and Analysis of Medication Errors in Latvia. Int J Environ Res Public Heal 2022, Vol 19, Page 10156. 2022 Aug 16;19(16):10156. DOI: 10.3390/IJERPH191610156
41. E-prescribing and dispensing of medicines in Europe. Available at: https://www.sns24.gov.pt/guia/a-minha-saude-na-europa/ prescricao-eletronica-e-dispensa-de-medicamentos-na-europa/
42. McKesson Europe Policy Position. 2018; Available at: https://ec.europa.eu/health/sites/health/files/ehealth/docs/ev_20161121_co091_en.pdf
43. Prescrição e dispensa - INFARMED, I.P. Available at: https://www.infarmed.pt/web/infarmed/profissionais-de-saude/ prescricao-e-dispensa
44. Ciências Farmacêuticas • EduPortugal. Available at: https://eduportugal.eu/opcoes-de-estudo/ciencias-farmaceuticas/
45. Paudyal V, Fialová D, Henman MC, Hazen A, Okuyan B, Lutters M, et al. Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy. Int J Clin Pharm. 2021 Aug; 43(4):1139–48. DOI: 10.1007/ S11096-021-01301-7
46. Portaria n.o 289/2023 | DR. Available at: https://diariodarepublica.pt/dr/detalhe/portaria/289-2023-222046015
47. Piraux A, Cavillon M, Ramond-Roquin A, Faure S. Assessment of Satisfaction with Pharmacist-Administered COVID-19 Vaccinations in France: PharmaCoVax. Vaccines. 2022 Mar 1;10(3). DOI: 10.3390/VACCINES10030440
48. French pharmacists now able to renew some doctor’s prescriptions. Available at: https://www.connexionfrance.com/practical/ french-pharmacists-now-able-to-renew-some-doctors-prescriptions/434978
49. Pharmacists in France allowed to renew and adjust repeat prescriptions. Available at: https://www.connexionfrance.com/ practical/pharmacists-in-france-allowed-to-renew-and-adjust-repeat-prescriptions/408024
50. van Loon WE, Borgsteede SD, Baas GW, Kruijtbosch M, Buurma H, De Smet PAGMP, et al. Nature and frequency of prescription modifications in community pharmacies: A nationwide study in the Netherlands. Br J Clin Pharmacol. 2021;87(3):1455–65.
51. Orçamento do Estado para 2023 | DR. Available at: https://diariodarepublica.pt/dr/legislacao-consolidada/lei/2022- 205695052
52. Portaria n.o 263/2023 | DR. Available at: https://diariodarepublica.pt/dr/detalhe/portaria/263-2023-219991258
53. A Vision for Community Pharmacy in Europe.
54. Statistics Portugal - Web Portal. Available at: https://www.ine.pt/xportal/xmain?xpid=INE&xpgid=ine_main
55. Chronic diseases and disabilities among older people | Health at a Glance: Europe 2022 : State of Health in the EU Cycle | OECD iLibrary. Available at: https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-europe- 2022_851d74d6-en
56. A pordata | PORDATA. Available at: https://www.pordata.pt/pt/pordata
57. Waszyk-Nowaczyk M, Guzenda W, Kamasa K, Pawlak K, Bałtruszewicz N, Artyszuk K, et al. Cooperation between pharmacists and physicians – whether it was before and is it still ongoing during the pandemic? J Multidiscip Healthc. 2021;14:2101–10.
58. Zhou S, Li R, Zhang X, Zong Y, Lei L, Tao Z, et al. The effects of pharmaceutical interventions on potentially inappropriate medications in older patients: a systematic review and meta-analysis. Front public Heal. 2023;11. DOI: 10.3389/FPUBH.2023.1154048
59. Hurmuz MZM, Janus SIM, van Manen JG. Changes in medicine prescription following a medication review in older high-risk patients with polypharmacy. Int J Clin Pharm. 2018 Apr 1;40(2):480–7. DOI: 10.1007/S11096-018-0602-3
60. Heinrich CH, McHugh S, McCarthy S, Curran GM, Donovan MD. Multidisciplinary DEprescribing review for Frail oldER adults in long-term care (DEFERAL): Implementation strategy design using behaviour science tools and stakeholder engagement. ResSocial Adm Pharm. 2023 Aug 1;19(8):1202–13. DOI: 10.1016/J.SAPHARM.2023.05.002
61. Harjaningsih W, Harjaningsih W. The Role of Clinical Pharmacists as a Collaborative Team for Ambulatory Care in Schizophrenic Patients. Curr Trends Ambul Care. 2023 Apr 26; DOI: 10.5772/INTECHOPEN.111507
62. Hammour KA, Farha RA, Ya’acoub R, Salman Z, Basheti I. Impact of Pharmacist-Directed Medication Reconciliation in Reducing Medication Discrepancies: A Randomized Controlled Trial. Can J Hosp Pharm. 2022 Jun 1;75(3):169–77. DOI: 10.4212/CJHP.3143
63. Amjad A, Kordel P, Fernandes G. A Review on Innovation in Healthcare Sector (Telehealth) through Artificial Intelligence. Sustain 2023, Vol 15, Page 6655. 2023 Apr 14;15(8):6655. DOI: 10.3390/SU15086655
64. Rahayu SA, Widianto S, Defi IR, Abdulah R. Role of pharmacists in the interprofessional care team for patients with chronic diseases. J Multidiscip Healthc. 2021;14:1701–10.
65. Ihm SH, Kim K Il, Lee KJ, Won JW, Na JO, Rha SW, et al. Interventions for Adherence Improvement in the Primary Prevention of Cardiovascular Diseases: Expert Consensus Statement. Korean Circ J. 2022 Jan 1;52(1). DOI: 10.4070/KCJ.2021.0226
66. Félix J, Ferreira D, Afonso-Silva M, Gomes MV, Ferreira C, Vandewalle B, et al. Social and economic value of Portuguese community pharmacies in health care. BMC Health Serv Res. 2017 Aug 29;17(1):1–12. DOI: 10.1186/S12913-017-2525-4/ TABLES/2
67. van Loon WE, Borgsteede SD, Baas GW, Kruijtbosch M, Buurma H, De Smet PAGMP, et al. Nature and frequency of prescription modifications in community pharmacies: A nationwide study in the Netherlands. Br J Clin Pharmacol. 2021 Mar 1; 87(3):1455–
65. DOI: 10.1111/BCP.14548
68. Smale EM, Egberts TCG, Heerdink ER, van den Bemt BJF, Bekker CL. Waste-minimising measures to achieve sustainable supply and use of medication. Sustain Chem Pharm. 2021 May 1;20.
69. Hurley-Kim K, Keyvani A, Ahmed R, Wong HW, McBane S. Pharmacist-Managed Refill Service Impacts on Clinician Workload and Medication Interventions in a Federally Qualified Health Center. J Prim Care Community Heal. 2023;14.
70. Billups SJ, Delate T, Newlon C, Schwiesow S, Jahnke R, Nadrash A. Outcomes of a pharmacist-managed medication refill program. J Am Pharm Assoc (2003). 2013;53(5):505–12. DOI: 10.1331/JAPHA.2013.13008
Article Sidebar
Published
Oct 8, 2025
Article Details
How to Cite
1.
An overview on pharmacist-managed prescription renewal. Pharm Pract (Granada) [Internet]. 2025 Oct. 8 [cited 2025 Oct. 22];23(3):1-9. Available from: https://pharmacypractice.org/index.php/pp/article/view/3146
Section
Review
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
1.
An overview on pharmacist-managed prescription renewal. Pharm Pract (Granada) [Internet]. 2025 Oct. 8 [cited 2025 Oct. 22];23(3):1-9. Available from: https://pharmacypractice.org/index.php/pp/article/view/3146